Amundi Oric Pharmaceuticals, Inc. Transaction History
Amundi
- $275 Billion
- Q1 2025
A detailed history of Amundi transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Amundi holds 178 shares of ORIC stock, worth $941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178Holding current value
$941% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
144Shares Held
75.9MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$34.8 Million0.12% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$28 Million6.85% of portfolio
-
Nextech Invest Ag5.29MShares$28 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$25.6 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$21.2 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $209M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...